Fallback

We’re sorry, but we can’t find the page you were looking for. It’s probably something we’ve done wrong but now we know about it and we’ll try to fix it. In the meantime, try one of these options:

HOMEPAGE SHOP WEBINARS

News on Pharma Excipients

Biopharma

mRNA Formulation Challenges: Stabilizing Delicate Strands with pH Control and Advanced Lipid Nanoparticles

16. June 2026

Messenger RNA (mRNA) is intrinsically unstable due to spontaneous 2'-hydroxyl-mediated phosphodiester hydrolysis, with degradation rates accelerating at pH below 5.0 and above 8.0 . Successful mRNA formulation requires a multi-layered protection strategy: nucleoside modification (N1-methylpseudouridine) at the molecular level, lipid...

Physical stability of salbutamol amorphous solid dispersion tablets measured by terahertz spectroscopy

15. June 2026

The ANDA Process: A Step-by-Step Guide to Generic Drug Approval

15. June 2026

Preparation of apixaban-cyclodextrin – D-α-tocopheryl polyethylene glycol 1000 succinate supramolecular inclusion complex: Mechanistic and physicochemical assessment

14. June 2026

Interview 3: 5 to 7 liters of water per kilogram: why pharmaceutical lactose is so thirsty

14. June 2026

Compressed Medicated Chewing Gum with Lysozyme Hydrochloride and Ascorbic Acid for Xerostomia Relief and Oral Health Support: Formulation Development, Optimization, In Vitro and In Vivo Evaluation

13. June 2026

One Formulation. Multiple Doses. Faster Development.